Edwards Lifesciences Corporation Stock price

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
95.56 USD +0.43% Intraday chart for Edwards Lifesciences Corporation +0.93% +25.32%
Sales 2024 * 6.52B Sales 2025 * 7.17B Capitalization 57.27B
Net income 2024 * 1.62B Net income 2025 * 1.82B EV / Sales 2024 * 8.49 x
Net cash position 2024 * 1.95B Net cash position 2025 * 3.19B EV / Sales 2025 * 7.54 x
P/E ratio 2024 *
35.5 x
P/E ratio 2025 *
31.7 x
Employees 19,800
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.52%
More Fundamentals * Assessed data
Dynamic Chart
North American Morning Briefing : Stocks Edge -2- DJ
Edwards Lifesciences Longtime Chair To Retire DJ
Sector Update: Health Care Stocks Higher in Late Afternoon Trading MT
Sector Update: Health Care Stocks Higher in Afternoon Trading MT
Edwards Lifesciences Likely to Benefit From 'Renaissance' in TMTT Segment, Says Morgan Stanley MT
Morgan Stanley Lifts Price Target on Edwards Lifesciences to $103 From $95, Sees 'Upside Risk' Amid Transcatheter Mitral & Tricuspid Therapies, Overweight Rating Kept MT
Oppenheimer Raises Edwards Lifesciences Price Target to $100 From $93, Maintains Outperform Rating MT
Edwards Lifesciences Insider Sold Shares Worth $1,319,696, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $1,320,149, According to a Recent SEC Filing MT
Edwards Lifesciences Announces Large, Real-World Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR CI
North American Morning Briefing : Stock Futures -2- DJ
BofA Securities Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $97 MT
Transcript : Edwards Lifesciences Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 10:30 AM
Edwards Lifesciences Insider Sold Shares Worth $2,543,737, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $620,923, According to a Recent SEC Filing MT
More news
1 day+1.85%
1 week+2.27%
Current month+12.11%
1 month+9.99%
3 months+24.85%
6 months+35.72%
Current year+24.79%
More quotes
1 week
92.96
Extreme 92.96
95.35
1 month
83.61
Extreme 83.61
95.35
Current year
71.67
Extreme 71.67
95.35
1 year
60.57
Extreme 60.57
95.35
3 years
60.57
Extreme 60.57
131.73
5 years
51.51
Extreme 51.5067
131.73
10 years
12.01
Extreme 12.0067
131.73
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 14-12-31
Chairman 71 99-12-31
Director of Finance/CFO 57 13-12-31
Members of the board TitleAgeSince
Director/Board Member 63 16-07-04
Director/Board Member 67 14-11-12
Director/Board Member 72 16-03-15
More insiders
Date Price Change Volume
24-03-28 95.56 +0.43% 4 007 449
24-03-27 95.15 +1.85% 3,656,907
24-03-26 93.42 +0.28% 2,750,083
24-03-25 93.16 -0.67% 2,497,213
24-03-22 93.79 -0.94% 2,452,996

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - hemodynamic monitoring systems (65.4%); - heart valves and surgery products (18.7%); - other (15.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.2%), Europe (21.8%), Japan (8.8%) and other (11.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
95.15 USD
Average target price
92.11 USD
Spread / Average Target
-3.19%
Consensus
  1. Stock
  2. Equities
  3. Stock Edwards Lifesciences Corporation - Nyse